Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Myriad Genetics Inc MYGN

Healthcare Biotechnology
Myriad Genetics, Inc. is a genetic testing and precision medicine company. The Company develops and offers genetic tests that help assess the risk of developing disease or disease progression and guide treatment decisions across medical specialties where genetic insights can significantly improve patient care and lower healthcare costs. The Company is focused on three key areas where it has... see more

Recent & Breaking News (NDAQ:MYGN)

Myriad to Present New Data on Its myRisk(TM) Hereditary Cancer Test at the CGA-ICC Annual Meeting

GlobeNewswire October 9, 2015

Myriad Genetics to Highlight New Clinical Outcomes Data on myPath(R) Melanoma at the American Society of Dermatopathology Annual Meeting

GlobeNewswire October 8, 2015

Myriad Genetics and Tufts Health Plan Sign Agreement to Cover Prolaris(R) for Members With Localized Prostate Cancer

GlobeNewswire October 7, 2015

Myriad to Present Seven Studies at the ASHG Annual Meeting

GlobeNewswire October 5, 2015

Myriad Appoints Jan Schluchter as Chief Commercial Officer for Europe

Thomson Reuters ONE October 1, 2015

Myriad Appoints Jan Schluchter as Chief Commercial Officer for Europe

GlobeNewswire October 1, 2015

Myriad Genetics Presents New Data on Its Companion Diagnostic and Prostate Cancer Tests at the European Society for Medical Oncology Annual Meeting

Thomson Reuters ONE September 24, 2015

Myriad Genetics Presents New Data on Its Companion Diagnostic and Prostate Cancer Tests at the European Society for Medical Oncology Annual Meeting

GlobeNewswire September 24, 2015

Myriad Genetics to Present at the 2015 Morgan Stanley Healthcare Conference

GlobeNewswire September 14, 2015

Myriad Genetics, Inc. (Nasdaq: MYGN) to Ring The Nasdaq Stock Market Opening Bell

GlobeNewswire September 11, 2015

Myriad Adds to Scientific Evidence for the myPlan(R) Lung Cancer Prognostic Test

GlobeNewswire September 9, 2015

Myriad Genetics to Host 2015 Investor Day in New York City

GlobeNewswire September 2, 2015

Crescendo Bioscience Names Elena Hitraya M.D., Ph.D., as Chief Medical Officer

GlobeNewswire September 1, 2015

Myriad Receives Favorable Medicare Final Coverage Decision for the Prolaris(R) Test

GlobeNewswire August 13, 2015

Myriad Genetics Reports Fiscal Fourth-Quarter and Full Year 2015 Financial Results

GlobeNewswire August 11, 2015

Myriad to Announce Fiscal Fourth Quarter 2015 Financial Results on August 11, 2015

GlobeNewswire July 29, 2015

Chris4Life and Myriad Launch "What's Your History" Week and FamilyHistoryTool(TM)

GlobeNewswire June 24, 2015

Myriad Presents New myRisk(TM) Hereditary Cancer Data at 2015 ASCO Annual Meeting

GlobeNewswire May 29, 2015

Myriad Significantly Advances the myChoice(R) HRD(TM) Companion Diagnostic Test

GlobeNewswire May 29, 2015

Myriad Genetics to Present at the 2015 Goldman Sachs Healthcare Conference

GlobeNewswire May 28, 2015
USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse
Later
Participate
Not interested